Combined sulforaphane and β-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways

Autor: El-Shoura, Ehab A.M., Abdelzaher, Lobna A., Mahmoud, Nesreen I., Farghaly, Omar A., Sabry, Mostafa, Girgis Shahataa, Mary, Salem, Esraa A., Saad, Hebatallah M., Elhussieny, Omnya, Kozman, Magy R., Atwa, Ahmed M.
Zdroj: In International Immunopharmacology 25 October 2024 140
Databáze: ScienceDirect
Externí odkaz: